BFA
MRNS

BlackRock Fund Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

BlackRock Fund Advisors’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$103K Buy
25,426
+3,863
+18% +$18K ﹤0.01% 3605
2016
Q3 		$157K Buy
21,563
+12,728
+144% +$86K ﹤0.01% 3527
2016
Q2 		$45K Buy
8,835
+5,527
+167% +$102K ﹤0.01% 3848
2016
Q1 		$71K Sell
3,308
-155
-4% -$3.28K ﹤0.01% 3740
2015
Q4 		$106K Buy
3,463
+408
+13% +$12K ﹤0.01% 3716
2015
Q3 		$102K Buy
+3,055
New +$172K ﹤0.01% 3696

Other funds holding MRNS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $2.24B AUM 17.11% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return